Since cancer studies almost exclusively characterize EMT as dedifferentiation 34, the differentiation promoted by the LBH gene could be considered to indicate EMT inhibition in LBH-overexpressing NPC xenografts. The gene discussed is LBH; the disease is nasopharyngeal carcinoma.